Avi I. Einzig
Impact in
- Oncology top 2%
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Dermatology top 5%
- Chemotherapy-related skin toxicity
Papers in
- Oncology 29
- Cancer Treatment and Pharmacology 20
- Colorectal Cancer Treatments and Studies 8
- HER2/EGFR in Cancer Research 3
-
- Gastric Cancer Management and Outcomes 6
- Lung Cancer Treatments and Mutations 3
- Renal cell carcinoma treatment 2
- Co-authors
- Peter H. Wiernik (15 shared papers)Janice P. Dutcher (4 shared papers)Richard B. Lipton (2 shared papers)Gary L. Goldberg (2 shared papers)Carolyn D. Runowicz (2 shared papers)Edward L. Schwartz (4 shared papers)J Strauman (1 shared paper)Al B. Benson (3 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Investigational New Drugs (4 papers)Medical Oncology (2 papers)Cancer (2 papers)Cancer Investigation (2 papers)
- Partner nations
- United StatesItalyJapan
In The Last Decade
Avi I. Einzig
37 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 86
- Oncology 1.1k
- Dermatology 124
- Reproductive Medicine 106
- Pulmonary and Respiratory Medicine 370
- Hematology 106
Countries citing papers authored by Avi I. Einzig
This map shows the geographic impact of Avi I. Einzig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avi I. Einzig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avi I. Einzig more than expected).
Fields of papers citing papers by Avi I. Einzig
This network shows the impact of papers produced by Avi I. Einzig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avi I. Einzig. The network helps show where Avi I. Einzig may publish in the future.
Co-authors
The 25 scholars most cited alongside Avi I. Einzig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 277 | |
| 2 | 1987 | 245 | |
| 3 | 1992 | 225 | |
| 4 | 1996 | 171 | |
| 5 | 1991 | 156 | |
| 6 | 2004 | 87 | |
| 7 | 1997 | 57 | |
| 8 | 1993 | 57 | |
| 9 | 1991 | 46 | |
| 10 | 2000 | 43 | |
| 11 | 1991 | 35 | |
| 12 | 1996 | 33 | |
| 13 | Taxol in malignant melanoma. | 1993 | 33 |
| 14 | 1995 | 31 | |
| 15 | 1996 | 26 | |
| 16 | 1993 | 25 | |
| 17 | 1992 | 25 | |
| 18 | 1996 | 21 | |
| 19 | 1993 | 21 | |
| 20 | 2002 | 19 |
About Avi I. Einzig
Avi I. Einzig is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Dermatology and Cell Biology, having authored 37 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (20 papers), Colorectal Cancer Treatments and Studies (8 papers), Gastric Cancer Management and Outcomes (6 papers), Chemotherapy-related skin toxicity (5 papers), Microtubule and mitosis dynamics (3 papers), HER2/EGFR in Cancer Research (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Oncology (1.1k citations), Dermatology (124 citations), Reproductive Medicine (106 citations), Pulmonary and Respiratory Medicine (370 citations) and Hematology (106 citations). Avi I. Einzig has collaborated with scholars based in United States, Italy and Japan. Frequent co-authors include Peter H. Wiernik, Janice P. Dutcher, Richard B. Lipton, Gary L. Goldberg, Carolyn D. Runowicz, Edward L. Schwartz, J Strauman, Al B. Benson, Herbert H. Schaumburg and Stuart C. Apfel. Their work appears in journals such as Journal of Clinical Oncology, Investigational New Drugs, Medical Oncology, Cancer and Cancer Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.